SEARCH
Surajit Pal of Prabhudas Lilladher on Dr Reddy's Laboratories
CNBC-TV18
2019-02-15
Views
1
Description
Share / Embed
Download This Video
Report
Shares of Dr Reddy's Laboratories plunged nearly 23 percent after a research report flagged USFDA observation issued at the company's formulation plant.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x72ftex" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
03:07
Interview with G.V. Prasad of Dr Reddy's Laboratories
10:06
Stocks To Watch: Dr Reddy’s Laboratories, Essel Propack & Ashok Leyland
08:09
Stocks To Watch: Steel Manufacturers, NMDC & Dr Reddy's Laboratories
09:22
Dr Reddy's Laboratories Profit Up 11%, In Line With Estimates | NDTV Profit
06:24
Stronger Q2 From Dr Reddy's Laboratories
06:59
Dr Reddy's Laboratories Q4 net up 2% at Rs 343 cr
04:33
Buy Ashok Leyland & Dr Reddy's Laboratories, says stock expert Prakash Gaba
01:56
Dr Reddy's Laboratories & Lupin will be in focus today
05:14
महापालिकेचे लसीसाठीचे प्रयत्न फोल | Sputnik V | Dr Reddy’s Laboratories | BMC | Mumbai News
01:59
Dealing Room Heroes | Prabhudas Lilladher
06:28
Expectations from IT results muted: Prabhudas Lilladher
06:01
Positive on Cholamandalam Finance, M&M Finance & Shriram Transport Finance, says Ajay Bodke of Prabhudas Lilladher
